{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:29:40Z","timestamp":1794439780877,"version":"4.9.1"},"reference-count":506,"publisher":"Oxford University Press (OUP)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,14]]},"DOI":"10.1093\/eurheartj\/ehu284","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T20:30:09Z","timestamp":1409430609000},"page":"2733-2779","source":"Crossref","is-referenced-by-count":3649,"title":["2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy"],"prefix":"10.1093","volume":"35","author":[{"name":"Authors\/Task Force members","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry M.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris","family":"Anastasakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Borger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Alain","family":"Hagege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Lafont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Mahrholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Nihoyannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Nistri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petronella G.","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkert","family":"Pieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rapezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Tillmanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Additional Contributor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"O'Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Committee for Practice Guidelines (CPG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christi","family":"Deaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7etin","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fagard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hasdai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno W.","family":"Hoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Knuuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Nihoyannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo F.","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Anton","family":"Sirnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Tamargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Tendera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Document Reviewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hasdai","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alfonso","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Basso","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno Miguel","family":"Cardim","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ram\u00f3n","family":"Gimeno","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Heymans","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Johan","family":"Holm","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Keren","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Lionis","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Muneretto","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Priori","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jesus","family":"Salvador","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wolpert","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Frick","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Aliyev","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Komissarova","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Mairesse","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnur","family":"Smaji\u0107","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasil","family":"Velchev","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loizos","family":"Antoniades","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Linhart","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Bundgaard","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Heli\u00f6","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Leenhardt","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A.","family":"Katus","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Efthymiadis","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Sepp","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Thor Gunnarsson","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shemy","family":"Carasso","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Kerimkulova","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginta","family":"Kamzola","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hady","family":"Skouri","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Eldirsi","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausra","family":"Kavoliuniene","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Felice","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Hermann Haugaa","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw","family":"Lenarczyk","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Brito","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Apetrei","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Bokheria","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Lovic","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hatala","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garcia Pav\u00eda","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eriksson","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Noble","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta","family":"Srbinovska","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Nesukay","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sekhri","sequence":"additional","affiliation":[{"name":"The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org\/guidelines"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,29]]},"reference":[{"key":"2026080919370481400_EHU284C1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C2","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","article-title":"Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence","volume":"33","author":"Spoladore","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9149(87)80107-8","article-title":"Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening","volume":"59","author":"Hada","year":"1987","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","article-title":"Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984","volume":"80","author":"Codd","year":"1989","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199808063390602","article-title":"Screening for hypertrophic cardiomyopathy in young athletes","volume":"339","author":"Corrado","year":"1998","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C7","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(99)00039-X","article-title":"Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities","volume":"33","author":"Maron","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"1021\u20131023, A8","key":"2026080919370481400_EHU284C8","article-title":"Screening for hypertrophic cardiomyopathy in a young male military population","volume":"91","author":"Nistri","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am J Med"},{"key":"2026080919370481400_EHU284C10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.amjcard.2004.03.007","article-title":"Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study)","volume":"93","author":"Maron","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1258\/004947506778604904","article-title":"Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania","volume":"36","author":"Maro","year":"2006","journal-title":"Trop Doct"},{"key":"2026080919370481400_EHU284C12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/europace\/eur051","article-title":"Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol","volume":"13","author":"Ng","year":"2011","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C14","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.104.530303","article-title":"Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study","volume":"112","author":"Nugent","year":"2005","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0025-6196(11)61527-9","article-title":"Yield of genetic testing in hypertrophic cardiomyopathy","volume":"80","author":"Van Driest","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"2026080919370481400_EHU284C16","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa075463","article-title":"Shared genetic causes of cardiac hypertrophy in children and adults","volume":"358","author":"Morita","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.repc.2011.12.020","article-title":"Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population","volume":"31","author":"Brito","year":"2012","journal-title":"Rev Port Cardiol"},{"key":"2026080919370481400_EHU284C18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12265-012-9425-0","article-title":"Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program","volume":"6","author":"Kassem","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"key":"2026080919370481400_EHU284C19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jmedgenet-2012-101270","article-title":"Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughputsequencing","volume":"50","author":"Lopes","year":"2013","journal-title":"J Med Genet"},{"key":"2026080919370481400_EHU284C20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra0902923","article-title":"Inherited cardiomyopathies","volume":"364","author":"Watkins","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2217\/bmm.13.79","article-title":"Genetic biomarkers in hypertrophic cardiomyopathy","volume":"7","author":"Coats","year":"2013","journal-title":"Biomark Med"},{"key":"2026080919370481400_EHU284C22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0025-6196(11)60890-2","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2026080919370481400_EHU284C25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","article-title":"Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations","volume":"58","author":"Olivotto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCGENETICS.111.959973","article-title":"Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene","volume":"5","author":"Pasquale","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080919370481400_EHU284C28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0735-1097(96)00530-X","article-title":"Sudden death due to troponin T mutations","volume":"29","author":"Moolman","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.98.5.391","article-title":"Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis","volume":"98","author":"Anan","year":"1998","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.amjcard.2003.08.031","article-title":"Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany","volume":"92","author":"Torricelli","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1006\/jmcc.1996.0322","article-title":"Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy","volume":"29","author":"Nakajima-Taniguchi","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"2026080919370481400_EHU284C32","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C33","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2005.033886","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling","volume":"42","author":"Ingles","year":"2005","journal-title":"J Med Genet"},{"key":"2026080919370481400_EHU284C34","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C35","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations","volume":"55","author":"Girolami","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C36","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1136\/heartjnl-2011-300364","article-title":"Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey","volume":"97","author":"Elliott","year":"2011","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2004.11.053","article-title":"Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history","volume":"45","author":"Murphy","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/hrt.2003.029504","article-title":"Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey","volume":"90","author":"Charron","year":"2004","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/fca.11.79","article-title":"Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course","volume":"8","author":"Limongelli","year":"2012","journal-title":"Future Cardiol"},{"key":"2026080919370481400_EHU284C40","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2026080919370481400_EHU284C41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ahj.2010.10.038","article-title":"Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA)","volume":"161","author":"Lagedrost","year":"2011","journal-title":"Am Heart J"},{"key":"2026080919370481400_EHU284C42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2459\/JCM.0b013e3283641c69","article-title":"Skeletal muscle involvement in cardiomyopathies","volume":"14","author":"Limongelli","year":"2013","journal-title":"J Cardiovasc Med (Hagerstown )"},{"key":"2026080919370481400_EHU284C43","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1093\/hmg\/dds157","article-title":"Evidence for FHL 1 as a novel disease gene for isolated hypertrophic cardiomyopathy","volume":"21","author":"Friedrich","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2026080919370481400_EHU284C44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jns.2004.01.007","article-title":"Desmin-related myopathy: clinical, electrophysiological, radiological, neuropathological and genetic studies","volume":"219","author":"Olive","year":"2004","journal-title":"J Neurol Sci"},{"key":"2026080919370481400_EHU284C45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2012.04.018","article-title":"Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry","volume":"164","author":"Wilkinson","year":"2012","journal-title":"Am Heart J"},{"key":"2026080919370481400_EHU284C46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.amjcard.2007.03.093","article-title":"Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome","volume":"100","author":"Limongelli","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-3-13","article-title":"Leopard syndrome","volume":"3","author":"Sarkozy","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"2026080919370481400_EHU284C48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.10558","article-title":"Further delineation of cardiac abnormalities in Costello syndrome","volume":"111","author":"Lin","year":"2002","journal-title":"Am J Med Genet"},{"key":"2026080919370481400_EHU284C49","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1253\/jcj.65.863","article-title":"Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study","volume":"65","author":"Hiramitsu","year":"2001","journal-title":"Jpn Circ J"},{"key":"2026080919370481400_EHU284C51","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: A JACC White Paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C52","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/eurheartj\/ehl416","article-title":"Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study","volume":"28","author":"Ullmo","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C53","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1378\/chest.109.5.1394","article-title":"Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopathy","volume":"109","author":"Huddle","year":"1996","journal-title":"Chest"},{"key":"2026080919370481400_EHU284C54","first-page":"186","article-title":"The nature of cardiac hypertrophy in acromegaly: an echocardiographic study","volume":"30","author":"Hradec","year":"1988","journal-title":"Cor Vasa"},{"key":"2026080919370481400_EHU284C55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-3046.2005.00260.x","article-title":"Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient","volume":"9","author":"Jarzembowski","year":"2005","journal-title":"Pediatr Transplant"},{"key":"2026080919370481400_EHU284C56","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1249\/00005768-199311000-00006","article-title":"The effects of anabolic steroids on myocardial structure and cardiovascular fitness","volume":"25","author":"Sachtleben","year":"1993","journal-title":"Med Sci Sports Exerc"},{"key":"2026080919370481400_EHU284C57","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/0961203312462757","article-title":"Evidence for risk of cardiomyopathy with hydroxychloroquine","volume":"21","author":"Sumpter","year":"2012","journal-title":"Lupus"},{"key":"2026080919370481400_EHU284C58","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/heart.83.6.667","article-title":"Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe","volume":"83","author":"Kampmann","year":"2000","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/hrt.77.2.130","article-title":"Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families","volume":"77","author":"McKenna","year":"1997","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C60","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.CIR.96.1.214","article-title":"Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population","volume":"96","author":"Charron","year":"1997","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0167-5273(02)00534-X","article-title":"Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population","volume":"90","author":"Charron","year":"2003","journal-title":"Int J Cardiol"},{"key":"2026080919370481400_EHU284C62","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/euhj.1997.0735","article-title":"Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy","volume":"19","author":"Hagege","year":"1998","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.CIR.104.2.128","article-title":"Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy","volume":"104","author":"Nagueh","year":"2001","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0002-9149(02)02434-7","article-title":"Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy","volume":"90","author":"Cardim","year":"2002","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C65","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1253\/jcj.62.811","article-title":"Solitary papillary muscle hypertrophy as a possible form of hypertrophic cardiomyopathy","volume":"62","author":"Kobashi","year":"1998","journal-title":"Jpn Circ J"},{"key":"2026080919370481400_EHU284C66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C67","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jacc.2009.02.071","article-title":"Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram","volume":"54","author":"McLeod","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C69","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C70","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","article-title":"Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy","volume":"45","author":"Adabag","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C71","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0002-9149(86)90286-9","article-title":"Variability of ventricular arrhythmias in hypertrophic cardiomyopathy and implications for treatment","volume":"58","author":"Mulrow","year":"1986","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C72","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","author":"Guttmann","year":"2013","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C73","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)","author":"O'Mahony","year":"2013;: 10.1093\/\/439","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C74","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C76","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.CIR.63.2.409","article-title":"Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography. Identification by wide-angle two-dimensional echocardiography","volume":"63","author":"Maron","year":"1981","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0735-1097(83)80269-1","article-title":"Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study","volume":"2","author":"Shapiro","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0033-0620(85)90024-6","article-title":"Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review","volume":"28","author":"Wigle","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080919370481400_EHU284C79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0894-7317(88)80062-2","article-title":"Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy","volume":"1","author":"Rakowski","year":"1988","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919370481400_EHU284C80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-7120-8-7","article-title":"Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment","volume":"8","author":"Losi","year":"2010","journal-title":"Cardiovasc Ultrasound"},{"key":"2026080919370481400_EHU284C81","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ejechocard\/jep005","article-title":"Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography","volume":"10","author":"Senior","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026080919370481400_EHU284C82","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C83","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1093\/eurheartj\/ehl383","article-title":"Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C84","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C85","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/hrt.2007.126003","article-title":"Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy","volume":"94","author":"Shah","year":"2008","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C86","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.84.3.1188","article-title":"Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction","volume":"84","author":"Klues","year":"1991","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C87","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.CIR.88.2.548","article-title":"Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy. Anatomic validation from mitral valve specimen","volume":"88","author":"Klues","year":"1993","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C88","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.amjcard.2007.10.032","article-title":"Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"101","author":"Harrigan","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C89","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/hrt.2007.118018","article-title":"Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"94","author":"Kwon","year":"2008","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C90","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1161\/01.CIR.98.23.2505","article-title":"Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle","volume":"98","author":"Maron","year":"1998","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C91","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/heart.86.6.709","article-title":"Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy","volume":"86","author":"Wigle","year":"2001","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C92","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jacc.2009.03.052","article-title":"Reflections of inflections in hypertrophic cardiomyopathy","volume":"54","author":"Sherrid","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C93","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1540-8175.2008.00851.x","article-title":"Left ventricular outflow tract gradient provoked by upright position or exercise in treated patients with hypertrophic cardiomyopathy without obstruction at rest","volume":"26","author":"Dimitrow","year":"2009","journal-title":"Echocardiography"},{"key":"2026080919370481400_EHU284C94","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9149(99)80416-0","article-title":"Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy","volume":"75","author":"Marwick","year":"1995","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C95","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.amjcard.2012.04.051","article-title":"b-blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy","volume":"110","author":"Nistri","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-7120-6-19","article-title":"Evaluation of left ventricular outflow tract gradient during treadmill exercise and in recovery period in orthostatic position, in patients with hypertrophic cardiomyopathy","volume":"6","author":"Miranda","year":"2008","journal-title":"Cardiovasc Ultrasound"},{"key":"2026080919370481400_EHU284C97","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.amjcard.2010.06.057","article-title":"Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy","volume":"106","author":"Nistri","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C98","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.echo.2010.10.006","article-title":"Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity","volume":"24","author":"Joshi","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919370481400_EHU284C99","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C100","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2006.05.013","article-title":"Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)","volume":"98","author":"Nistri","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C101","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.echo.2008.11.001","article-title":"Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy","volume":"22","author":"Losi","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919370481400_EHU284C102","doi-asserted-by":"crossref","DOI":"10.1186\/1476-7120-9-34","article-title":"Left atrial volume predicts adverse cardiac and cerebrovascular events in patients with hypertrophic cardiomyopathy","volume":"9","author":"Tani","year":"2011","journal-title":"Cardiovasc Ultrasound"},{"key":"2026080919370481400_EHU284C103","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"Nagueh","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026080919370481400_EHU284C104","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2007.02.061","article-title":"Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype","volume":"49","author":"Kubo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C105","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.amjcard.2009.07.057","article-title":"Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy","volume":"104","author":"Biagini","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C106","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.107.698985","article-title":"Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization","volume":"116","author":"Geske","year":"2007","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C107","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.echo.2011.05.009","article-title":"Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy","volume":"24","author":"Kitaoka","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919370481400_EHU284C108","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1378\/chest.128.5.3428","article-title":"Tissue Doppler-derived indices predict exercise capacity in patients with apical hypertrophic cardiomyopathy","volume":"128","author":"Ha","year":"2005","journal-title":"Chest"},{"key":"2026080919370481400_EHU284C109","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/ejechocard\/jeq185","article-title":"A new method for quantification of left ventricular systolic function using a corrected ejection fraction","volume":"12","author":"Maciver","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"2026080919370481400_EHU284C110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCIMAGING.113.000842","article-title":"Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy","volume":"7","author":"Urbano-Moral","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C111","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1161\/01.CIR.98.22.2415","article-title":"Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography","volume":"98","author":"Faber","year":"1998","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0735-1097(98)00220-4","article-title":"Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy","volume":"32","author":"Nagueh","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C113","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.euje.2004.01.001","article-title":"Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience","volume":"5","author":"Faber","year":"2004","journal-title":"Eur J Echocardiogr"},{"key":"2026080919370481400_EHU284C114","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/S0735-1097(00)01019-6","article-title":"Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy","volume":"36","author":"Yu","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0894-7317(05)80338-4","article-title":"Transesophageal echocardiographic evaluation of mitral regurgitation in hypertrophic cardiomyopathy: contributions of eccentric left ventricular hypertrophy and related abnormalities of the mitral complex","volume":"8","author":"Oki","year":"1995","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919370481400_EHU284C116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0735-1097(92)90135-A","article-title":"Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making","volume":"20","author":"Grigg","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C117","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/0735-1097(92)90359-U","article-title":"Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy","volume":"20","author":"Marwick","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C118","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ejechocard\/jeq057","article-title":"Recommendations for transoesophageal echocardiography: update 2010","volume":"11","author":"Flachskampf","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"2026080919370481400_EHU284C119","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","article-title":"Hypertrophic cardiomyopathy. Clinical spectrum and treatment","volume":"92","author":"Wigle","year":"1995","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C120","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C121","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","article-title":"Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy","volume":"357","author":"Elliott","year":"2001","journal-title":"Lancet"},{"key":"2026080919370481400_EHU284C122","first-page":"720","article-title":"Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation","volume":"9","author":"Kim","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"2026080919370481400_EHU284C123","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11886-007-0010-0","article-title":"Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy","volume":"9","author":"O'Hanlon","year":"2007","journal-title":"Curr Cardiol Rep"},{"key":"2026080919370481400_EHU284C124","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2008.04.047","article-title":"Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"52","author":"Olivotto","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ehjci\/jes145","article-title":"Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography","volume":"14","author":"Puntmann","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C126","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C127","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C128","first-page":"763","article-title":"Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy","volume":"68","author":"Spiewak","year":"2010","journal-title":"Kardiol Pol"},{"key":"2026080919370481400_EHU284C129","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jcmg.2011.03.017","article-title":"LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR","volume":"4","author":"Weinsaft","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C131","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ehjci\/jes005","article-title":"Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers","volume":"13","author":"Brouwer","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C132","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2006.08.036","article-title":"Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations","volume":"48","author":"Germans","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C133","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C134","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacc.2006.08.055","article-title":"Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy","volume":"49","author":"Valeti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C135","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.amjcard.2010.07.017","article-title":"Follow-up by cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy who underwent percutaneous ventricular septal ablation","volume":"106","author":"Yuan","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C136","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jacc.2008.08.064","article-title":"Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling","volume":"53","author":"Rudolph","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C137","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C138","first-page":"358","article-title":"Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy","volume":"29","author":"Prinz","year":"2013","journal-title":"Can J Cardiol"},{"key":"2026080919370481400_EHU284C139","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","article-title":"Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy","volume":"56","author":"Bruder","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C140","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C141","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","article-title":"Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy","volume":"3","author":"Rubinshtein","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C142","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C143","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.108.768119","article-title":"Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy","volume":"1","author":"Maron","year":"2008","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C144","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C145","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C146","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C147","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C148","volume-title":"Heart to Heart: Inherited Cardiovascular Conditions Services \u2013 A Needs Assessment and Service Review","author":"Burton","year":"2009"},{"key":"2026080919370481400_EHU284C149","article-title":"European Reference Networks in the Field of Rare Diseases: State of the Art and Future Directions (third report)","author":"Rare diseases task force"},{"key":"2026080919370481400_EHU284C150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jacc.2009.04.026","article-title":"Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia","volume":"54","author":"Kwon","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C151","first-page":"1","article-title":"Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging","volume":"10","author":"White","year":"1996","journal-title":"Am J Card Imaging"},{"key":"2026080919370481400_EHU284C152","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCIMAGING.112.000110","article-title":"Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy","volume":"6","author":"Bravo","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C153","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hfc.2006.04.001","article-title":"Review of noninvasive imaging for hypertrophic cardiac syndromes and restrictive physiology","volume":"2","author":"Fowler","year":"2006","journal-title":"Heart Fail Clin"},{"key":"2026080919370481400_EHU284C154","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.nuclcard.2006.05.018","article-title":"Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study","volume":"13","author":"Knaapen","year":"2006","journal-title":"J Nucl Cardiol"},{"key":"2026080919370481400_EHU284C155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ehjci\/jes242","article-title":"Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography","volume":"14","author":"Timmer","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C156","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C157","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","article-title":"Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy","volume":"38","author":"Rapezzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026080919370481400_EHU284C158","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jcmg.2012.02.015","article-title":"Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis","volume":"5","author":"Quarta","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C159","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/eurheartj\/ehm544","article-title":"Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology","volume":"29","author":"Schroeder","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcct.2013.04.002","article-title":"Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation\/ventricular tachycardia events in patients with hypertrophic cardiomyopathy","volume":"7","author":"Shiozaki","year":"2013","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026080919370481400_EHU284C161","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10554-012-0048-y","article-title":"Cardiac computed tomographic imaging to evaluate myocardial scarring\/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging","volume":"29","author":"Berliner","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C162","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","article-title":"2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology","volume":"21","author":"Leone","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"2026080919370481400_EHU284C163","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/eurheartj\/ehm456","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology","volume":"28","author":"Cooper","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C164","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.jacc.2013.04.004","article-title":"B-type natriuretic peptide and survival in hypertrophic cardiomyopathy","volume":"61","author":"Geske","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C165","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/eht070","article-title":"Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy","volume":"34","author":"Coats","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C166","first-page":"99","article-title":"Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease","volume":"7","author":"Niemann","year":"2013","journal-title":"JIMD Rep"},{"key":"2026080919370481400_EHU284C167","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.CIR.0000080896.52003.DF","article-title":"Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy","volume":"108","author":"Van Driest","year":"2003","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C168","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","article-title":"Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"31","author":"Charron","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C169","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.ejhg.5201111","article-title":"Provision of genetic services in Europe: current practices and issues","volume":"11 Suppl 2","author":"Godard","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"2026080919370481400_EHU284C170","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ejhg.5201113","article-title":"Population genetic screening programmes: principles, techniques, practices, and policies","volume":"11 Suppl 2","author":"Godard","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"2026080919370481400_EHU284C171","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1038\/sj.ejhg.5201117","article-title":"Genetic information and testing in insurance and employment: technical, social and ethical issues","volume":"11 Suppl 2","author":"Godard","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"2026080919370481400_EHU284C172","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.ejhg.5201484","article-title":"Research network: EuroGentest: a European Network of Excellence aimed at harmonizing genetic testing services","volume":"13","author":"Cassiman","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"2026080919370481400_EHU284C173","first-page":"1233","article-title":"Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents","volume":"57","author":"American Society of Human Genetics Board of Directors","year":"1995","journal-title":"Am J Hum Genet"},{"key":"2026080919370481400_EHU284C174","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/PDM.0b013e31820b34fb","article-title":"High-throughput genotyping robot-assisted method for mutation detection in patients with hypertrophic cardiomyopathy","volume":"20","author":"Bortot","year":"2011","journal-title":"Diagn Mol Pathol"},{"key":"2026080919370481400_EHU284C175","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jmg.2010.083345","article-title":"Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice","volume":"48","author":"Fokstuen","year":"2011","journal-title":"J Med Genet"},{"key":"2026080919370481400_EHU284C176","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4330\/wjc.v4.i10.288","article-title":"Next generation sequencing in cardiovascular diseases","volume":"4","author":"Faita","year":"2012","journal-title":"World J Cardiol"},{"key":"2026080919370481400_EHU284C177","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCGENETICS.110.958322","article-title":"Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies","volume":"4","author":"Meder","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080919370481400_EHU284C178","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/eurheartj\/ehr092","article-title":"Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy","volume":"32","author":"Christiaans","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C179","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/humu.20862","article-title":"Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives","volume":"30","author":"Andersen","year":"2009","journal-title":"Hum Mutat"},{"key":"2026080919370481400_EHU284C180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0008-6363(02)00711-3","article-title":"Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations","volume":"57","author":"Havndrup","year":"2003","journal-title":"Cardiovasc Res"},{"key":"2026080919370481400_EHU284C181","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2014.01.017","article-title":"Exome analysis based molecular autopsy in cases of sudden unexplained death in the young","author":"Bagnall","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080919370481400_EHU284C182","first-page":"391","article-title":"Guidelines for autopsy investigation of sudden cardiac death","volume":"102","author":"Basso","year":"2010","journal-title":"Pathologica"},{"key":"2026080919370481400_EHU284C183","article-title":"Guidelines for quality assurance in molecular genetic testing","author":"Organisation for Economic Co-operation and Development (OECD)","year":"2007","journal-title":"http:\/\/www oecd org\/dataoecd\/43\/6\/38839788 pdf"},{"key":"2026080919370481400_EHU284C184","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ajmg.a.32672","article-title":"Family letters are an effective way to inform relatives about inherited cardiac disease","volume":"149A","author":"van der Roest","year":"2009","journal-title":"Am J Med Genet A"},{"key":"2026080919370481400_EHU284C185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/heartjnl-2011-300368","article-title":"A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy","volume":"98","author":"Ingles","year":"2012","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C186","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/eurheartj\/ehq067","article-title":"DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model","volume":"31","author":"Wordsworth","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C187","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.108.817346","article-title":"Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"2","author":"Hershberger","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C188","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"2026080919370481400_EHU284C189","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.111.090514","article-title":"Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing","volume":"127","author":"Jensen","year":"2013","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C190","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1399-0004.2006.00692.x","article-title":"Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers","volume":"70","author":"Borry","year":"2006","journal-title":"Clin Genet"},{"key":"2026080919370481400_EHU284C191","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2702.2012.04108.x","article-title":"Quality of life in asymptomatic children and adolescents before and after diagnosis of hypertrophic cardiomyopathy through family screening","volume":"22","author":"Bratt","year":"2013","journal-title":"J Clin Nurs"},{"key":"2026080919370481400_EHU284C192","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/gim.2012.176","article-title":"Technical report: Ethical and policy issues in genetic testing and screening of children","volume":"15","author":"Ross","year":"2013","journal-title":"Genet Med"},{"key":"2026080919370481400_EHU284C193","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2011.07.095","article-title":"Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy","volume":"152","author":"Gray","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026080919370481400_EHU284C194","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ahj.2005.12.005","article-title":"Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes","volume":"151","author":"Poutanen","year":"2006","journal-title":"Am Heart J"},{"key":"2026080919370481400_EHU284C195","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/euhj.1998.1049","article-title":"Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children","volume":"19","author":"Charron","year":"1998","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C196","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/eurheartj\/ehq101","article-title":"Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging","volume":"31","author":"Gandjbakhch","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C197","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.hrthm.2009.04.029","article-title":"Ventricular fibrillation in MYH 7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy","volume":"6","author":"Christiaans","year":"2009","journal-title":"Heart Rhythm"},{"key":"2026080919370481400_EHU284C198","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/hrt.63.5.308","article-title":"Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass","volume":"63","author":"Maron","year":"1990","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C199","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy","volume":"338","author":"Niimura","year":"1998","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C200","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/hrt.2010.200402","article-title":"Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3","volume":"96","author":"Oliva-Sandoval","year":"2010","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C201","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCGENETICS.111.960831","article-title":"Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome","volume":"5","author":"Page","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080919370481400_EHU284C202","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/01.hjr.0000238393.96975.32","article-title":"Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis","volume":"13","author":"Pelliccia","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026080919370481400_EHU284C203","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/pd.969","article-title":"Prenatal molecular diagnosis in hypertrophic cardiomyopathy: report of the first case","volume":"24","author":"Charron","year":"2004","journal-title":"Prenat Diagn"},{"key":"2026080919370481400_EHU284C204","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bmj.322.7293.1048","article-title":"Integrated regional genetic services: current and future provision","volume":"322","author":"Donnai","year":"2001","journal-title":"BMJ"},{"key":"2026080919370481400_EHU284C205","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/clc.4960190509","article-title":"Symptoms of hypertrophic cardiomyopathy, with special emphasis on syncope and postprandial exacerbation of symptoms","volume":"19","author":"Gilligan","year":"1996","journal-title":"Clin Cardiol"},{"key":"2026080919370481400_EHU284C206","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.jacc.2013.02.079","article-title":"Post-prandial upright exercise echocardiography in hypertrophic cardiomyopathy","volume":"61","author":"Feiner","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C207","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM199609263351305","article-title":"The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy","volume":"335","author":"Paz","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C208","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C209","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/S0735-1097(00)00987-6","article-title":"Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease","volume":"36","author":"Mohiddin","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0735-1097(03)00854-4","article-title":"Myocardial bridging in adult patients with hypertrophic cardiomyopathy","volume":"42","author":"Sorajja","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C211","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","article-title":"Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death","volume":"30","author":"Basso","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C212","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/euhj.1997.0769","article-title":"Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome","volume":"19","author":"Yamada","year":"1998","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C213","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/oxfordjournals.eurheartj.a015002","article-title":"Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study","volume":"17","author":"Elliott","year":"1996","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C214","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/hrt.75.2.179","article-title":"Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy","volume":"75","author":"Elliott","year":"1996","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C215","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.nuclcard.2004.05.008","article-title":"Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications?","volume":"11","author":"Romero-Farina","year":"2004","journal-title":"J Nucl Cardiol"},{"key":"2026080919370481400_EHU284C216","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00004728-200605000-00011","article-title":"Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function","volume":"30","author":"Soler","year":"2006","journal-title":"J Comput Assist Tomogr"},{"key":"2026080919370481400_EHU284C217","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1590\/S0066-782X2009001000017","article-title":"Late enhancement and myocardial perfusion in hypertrophic cardiomyopathy (comparison between groups)","volume":"93","author":"Barbosa","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"2026080919370481400_EHU284C218","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C219","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/europace\/eul108","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society","volume":"8","author":"Zipes","year":"2006","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcct.2009.10.004","article-title":"Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy","volume":"4","author":"Okayama","year":"2010","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026080919370481400_EHU284C221","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.ijcard.2007.06.132","article-title":"Usefulness of multi-detector row computed tomography for the management of percutaneous transluminal septal myocardial ablation in patient with hypertrophic obstructive cardiomyopathy","volume":"129","author":"Mitsutake","year":"2008","journal-title":"Int J Cardiol"},{"key":"2026080919370481400_EHU284C222","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"31","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C223","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C224","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/hrt.2003.031161","article-title":"Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy","volume":"91","author":"Thaman","year":"2005","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C225","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C226","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C227","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006","volume":"25","author":"Mehra","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2026080919370481400_EHU284C228","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/euhj.1998.1155","article-title":"High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate","volume":"20","author":"Lindelow","year":"1999","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C229","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-5223(97)70053-9","article-title":"Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality","volume":"114","author":"Chen","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080919370481400_EHU284C230","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jcin.2012.01.026","article-title":"Assessment of left ventricular outflow gradient: hypertrophic cardiomyopathy versus aortic valvular stenosis","volume":"5","author":"Geske","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919370481400_EHU284C231","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0735-1097(00)00816-0","article-title":"Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes","volume":"36","author":"Sharma","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C232","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/hrt.81.4.441","article-title":"Diagnostic utility of metabolic exercise testing in a patient with cardiovascular disease","volume":"81","author":"Elliott","year":"1999","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C233","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9149(00)00854-7","article-title":"Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy","volume":"86","author":"Sharma","year":"2000","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C234","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0002-9149(92)90713-9","article-title":"Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy","volume":"69","author":"Diodati","year":"1992","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1249\/MSS.0b013e31816459a1","article-title":"Ventilatory efficiency and resting hemodynamics in hypertrophic cardiomyopathy","volume":"40","author":"Arena","year":"2008","journal-title":"Med Sci Sports Exerc"},{"key":"2026080919370481400_EHU284C236","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0735-1097(99)00094-7","article-title":"Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy","volume":"33","author":"Olivotto","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C237","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.96.9.2987","article-title":"Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy","volume":"96","author":"Sadoul","year":"1997","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C238","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/01.CIR.83.3.778","article-title":"Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure","volume":"83","author":"Mancini","year":"1991","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C239","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0300-8932(10)70210-4","article-title":"Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy","volume":"63","author":"Barriales-Villa","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"2026080919370481400_EHU284C240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.CIR.94.3.467","article-title":"Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy","volume":"94","author":"McCully","year":"1996","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C241","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.CIR.84.2.686","article-title":"Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy","volume":"84","author":"Counihan","year":"1991","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C242","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/hrt.2008.141507","article-title":"Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation","volume":"94","author":"Prasad","year":"2008","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C243","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1093\/eurheartj\/ehp298","article-title":"Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)","volume":"30","author":"Moya","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C244","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0735-1097(02)03004-8","article-title":"Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration","volume":"41","author":"Kofflard","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C245","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C246","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/eurheartj\/ehp327","article-title":"Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Gimeno","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C247","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjcard.2009.04.039","article-title":"Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy","volume":"104","author":"Efthimiadis","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C248","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1093\/eurheartj\/ehq308","article-title":"Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up","volume":"31","author":"Dimitrow","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C249","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/europace\/eup097","article-title":"Indications for the use of diagnostic implantable and external ECG loop recorders","volume":"11","author":"Brignole","year":"2009","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C251","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5935\/abc.20130032","article-title":"Evaluation of the autonomic function in patients with hypertrophic cardiomyopathy with and without syncope","volume":"100","author":"Macatrao-Costa","year":"2013","journal-title":"Arq Bras Cardiol"},{"key":"2026080919370481400_EHU284C252","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1161\/01.CIR.85.6.2140","article-title":"Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test","volume":"85","author":"Gilligan","year":"1992","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C253","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/europace\/eur130","article-title":"Management of patients with palpitations: a position paper from the European Heart Rhythm Association","volume":"13","author":"Raviele","year":"2011","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C254","first-page":"1493","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias: executive summary. a report of the American college of cardiology\/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society","volume":"42","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C255","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.CIR.80.5.1259","article-title":"Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients","volume":"80","author":"Fananapazir","year":"1989","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C256","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1540-8167.2010.01875.x","article-title":"Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy","volume":"22","author":"Inada","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919370481400_EHU284C257","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1540-8167.2008.01366.x","article-title":"Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm","volume":"20","author":"Lim","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919370481400_EHU284C258","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199908263410916","article-title":"Subaortic obstruction after sildenafil in a patient with hypertrophic cardiomyopathy","volume":"341","author":"Stauffer","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C259","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.26.2.166","article-title":"Studies on digitalis. V. Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis","volume":"26","author":"Braunwald","year":"1962","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C260","article-title":"Idiopathic hypertrophic subaortic stenosis. i) a description of the disease based upon an analysis of 64 patients","volume":"30","author":"Braunwald","year":"1964","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C261","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C262","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C263","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/hrt.32.6.804","article-title":"Long-term propranolol therapy in muscular subaortic stenosis","volume":"32","author":"Adelman","year":"1970","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C264","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0002-9149(73)90012-X","article-title":"Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy","volume":"31","author":"Stenson","year":"1973","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C265","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.38.5.846","article-title":"Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol","volume":"38","author":"Flamm","year":"1968","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C266","first-page":"335","article-title":"Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy","volume":"82","author":"Tendera","year":"1993","journal-title":"Cardiology"},{"key":"2026080919370481400_EHU284C267","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C268","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with beta-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C269","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.64.3.437","article-title":"Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy","volume":"64","author":"Epstein","year":"1981","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C270","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/01.CIR.60.6.1201","article-title":"Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects","volume":"60","author":"Rosing","year":"1979","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C271","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/4.suppl_F.57","article-title":"The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy","volume":"4 Suppl F","author":"Bonow","year":"1983","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C272","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.CIR.67.2.413","article-title":"Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy","volume":"67","author":"Spicer","year":"1983","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C273","doi-asserted-by":"crossref","first-page":"185B","DOI":"10.1016\/0002-9149(85)90630-7","article-title":"Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy","volume":"55","author":"Rosing","year":"1985","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C274","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1536\/ihj.27.701","article-title":"Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study","volume":"27","author":"Toshima","year":"1986","journal-title":"Jpn Heart J"},{"key":"2026080919370481400_EHU284C275","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/01.CIR.72.5.1001","article-title":"Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy","volume":"72","author":"Betocchi","year":"1985","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C276","first-page":"105","article-title":"Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy","volume":"76 Suppl 3","author":"Hopf","year":"1987","journal-title":"Z Kardiol"},{"key":"2026080919370481400_EHU284C277","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.echo.2007.11.006","article-title":"Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy","volume":"21","author":"Menon","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919370481400_EHU284C278","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.52.1.88","article-title":"Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients","volume":"52","author":"Morrow","year":"1975","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C279","first-page":"I57","article-title":"Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients","volume":"80","author":"Krajcer","year":"1989","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-5223(05)80026-1","article-title":"Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results","volume":"110","author":"Heric","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080919370481400_EHU284C281","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-5223(96)70310-0","article-title":"Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy","volume":"111","author":"Robbins","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080919370481400_EHU284C282","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0003-4975(98)00187-8","article-title":"Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy","volume":"65","author":"Schonbeck","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"2026080919370481400_EHU284C283","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2007-1013146","article-title":"Management of symptomatic hypertrophic obstructive cardiomyopathy: long-term results after surgical therapy","volume":"47","author":"Schulte","year":"1999","journal-title":"Thorac Cardiovasc Surg"},{"key":"2026080919370481400_EHU284C284","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C285","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.CIR.0000162460.36735.71","article-title":"Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy","volume":"111","author":"Woo","year":"2005","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C286","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.athoracsur.2007.07.063","article-title":"Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy","volume":"85","author":"Smedira","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2026080919370481400_EHU284C287","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.112.000849","article-title":"Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C288","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.athoracsur.2012.08.011","article-title":"Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults","volume":"95","author":"Altarabsheh","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2026080919370481400_EHU284C289","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/eurheartj\/ehs064","article-title":"A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy","volume":"33","author":"Iacovoni","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C290","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ncpcardio0965","article-title":"Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy - the Mayo Clinic experience","volume":"4","author":"Dearani","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2026080919370481400_EHU284C291","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0735-1097(96)00103-9","article-title":"Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy","volume":"28","author":"Kofflard","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C292","first-page":"II60","article-title":"Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy","volume":"86","author":"McIntosh","year":"1992","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C293","first-page":"II181","article-title":"Anterion-superior displacement of papillary muscles producing obstruction and mitral regurgitation in idiopathic hypertrophic subaortic stenosis. Operative relief by posterior-superior realignment of papillary muscles following ventricular septal myectomy","volume":"50","author":"Reis","year":"1974","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C294","doi-asserted-by":"crossref","first-page":"II122","DOI":"10.1161\/01.CIR.92.9.122","article-title":"Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus","volume":"92","author":"Schoendube","year":"1995","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C295","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.athoracsur.2008.01.061","article-title":"Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes","volume":"85","author":"Kaple","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2026080919370481400_EHU284C296","first-page":"137","article-title":"Mitral valve replacement and limited myectomy for hypertrophic obstructive cardiomyopathy: a 25-year follow-up","volume":"31","author":"Stassano","year":"2004","journal-title":"Tex Heart Inst J"},{"key":"2026080919370481400_EHU284C297","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jtcvs.2003.09.040","article-title":"Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae","volume":"127","author":"Minakata","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080919370481400_EHU284C298","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"2026080919370481400_EHU284C299","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00392-007-0578-9","article-title":"One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response","volume":"96","author":"Faber","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"2026080919370481400_EHU284C300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcin.2008.07.005","article-title":"Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007","volume":"1","author":"Fernandes","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919370481400_EHU284C301","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00392-007-0616-7","article-title":"Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience","volume":"97","author":"Kuhn","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"2026080919370481400_EHU284C302","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.107.738740","article-title":"Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"118","author":"Sorajja","year":"2008","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C303","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C304","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCHEARTFAILURE.109.862359","article-title":"Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution","volume":"3","author":"Ten Cate","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C305","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/eurheartj\/ehm632","article-title":"Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up","volume":"29","author":"Durand","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C306","first-page":"350","article-title":"Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy","volume":"61","author":"Iacob","year":"2004","journal-title":"Kardiol Pol"},{"key":"2026080919370481400_EHU284C307","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1583\/03-1171MR.1","article-title":"Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes","volume":"11","author":"Gross","year":"2004","journal-title":"J Endovasc Ther"},{"key":"2026080919370481400_EHU284C308","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1540-8183.2010.00605.x","article-title":"Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy","volume":"24","author":"Oto","year":"2011","journal-title":"J Interv Cardiol"},{"key":"2026080919370481400_EHU284C309","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2010.07.055","article-title":"Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy: acute results and 6 months' follow-up in 19 patients","volume":"57","author":"Lawrenz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C310","first-page":"247","article-title":"Feasibility study of percutaneous transvalvular endomyocardial cryoablation for the treatment of hypertrophic obstructive cardiomyopathy","volume":"19","author":"Keane","year":"2007","journal-title":"J Invasive Cardiol"},{"key":"2026080919370481400_EHU284C311","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2009.09.047","article-title":"Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy","volume":"55","author":"Agarwal","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C312","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/eurheartj\/ehp016","article-title":"Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis","volume":"30","author":"Alam","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C313","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2005.10.009","article-title":"Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a meta analysis","volume":"112","author":"Zeng","year":"2006","journal-title":"Int J Cardiol"},{"key":"2026080919370481400_EHU284C314","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCINTERVENTIONS.109.916676","article-title":"Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment","volume":"3","author":"Leonardi","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080919370481400_EHU284C315","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2006.07.179","article-title":"Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances","volume":"119","author":"Faber","year":"2007","journal-title":"Int J Cardiol"},{"key":"2026080919370481400_EHU284C316","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.amjcard.2012.10.014","article-title":"Comparison of surgical septal myectomy to medical therapy alone in patients with hypertrophic cardiomyopathy and syncope","volume":"111","author":"Orme","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C317","first-page":"380","article-title":"Mitral valve replacement for idiopathic hypertrophic subaortic stenosis. Results in 27 patients","volume":"17","author":"Cooley","year":"1976","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2026080919370481400_EHU284C318","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/hrt.75.1.44","article-title":"DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience","volume":"75","author":"Slade","year":"1996","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C319","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0735-1097(96)00473-1","article-title":"Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial","volume":"29","author":"Nishimura","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C320","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/oxfordjournals.eurheartj.a015435","article-title":"Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group","volume":"18","author":"Kappenberger","year":"1997","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C321","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)","volume":"99","author":"Maron","year":"1999","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C322","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/B:JICE.0000035929.84238.2f","article-title":"Doppler evaluation of the descending aorta in patients with hypertrophic cardiomyopathy: potential for assessing the functional significance of outflow tract gradients and for optimizing pacemaker function","volume":"11","author":"Mickelsen","year":"2004","journal-title":"J Interv Card Electrophysiol"},{"key":"2026080919370481400_EHU284C323","first-page":"333","article-title":"[Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy]","volume":"35","author":"Gao","year":"2007","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2026080919370481400_EHU284C324","first-page":"CD008523","article-title":"Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy","volume":"5","author":"Qintar","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919370481400_EHU284C325","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.amjcard.2006.01.040","article-title":"Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age","volume":"97","author":"Topilski","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C326","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1540-8159.1997.tb06173.x","article-title":"Dual chamber pacing in hypertrophic obstructive cardiomyopathy: beneficial effect of atrioventricular junction ablation for optimal left ventricular capture and filling","volume":"20","author":"Jeanrenaud","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080919370481400_EHU284C327","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/hrt.2010.217182","article-title":"The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy","volume":"98","author":"O'Mahony","year":"2012","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C328","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2011.02.033","article-title":"Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy","volume":"57","author":"Minami","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C329","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1253\/circj.CJ-12-1561","article-title":"Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction","volume":"77","author":"Efthimiadis","year":"2013","journal-title":"Circ J"},{"key":"2026080919370481400_EHU284C330","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1540-8175.2009.00905.x","article-title":"Severe symptoms in mid and apical hypertrophic cardiomyopathy","volume":"26","author":"Shah","year":"2009","journal-title":"Echocardiography"},{"key":"2026080919370481400_EHU284C331","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/hrt.61.2.178","article-title":"Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm","volume":"61","author":"Alfonso","year":"1989","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C332","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1540-8191.2012.01475.x","article-title":"Transapical approach for apical myectomy and relief of midventricular obstruction in hypertrophic cardiomyopathy","volume":"27","author":"Said","year":"2012","journal-title":"J Card Surg"},{"key":"2026080919370481400_EHU284C333","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.athoracsur.2013.04.073","article-title":"Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy","volume":"96","author":"Kunkala","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2026080919370481400_EHU284C334","first-page":"1754","article-title":"Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review","volume":"124","author":"Gao","year":"2011","journal-title":"Chin Med J (Engl )"},{"key":"2026080919370481400_EHU284C335","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2169\/internalmedicine.50.5079","article-title":"Two cases of cerebral embolism caused by apical thrombi in midventricular obstructive cardiomyopathy","volume":"50","author":"Takeda","year":"2011","journal-title":"Intern Med"},{"key":"2026080919370481400_EHU284C336","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3349\/ymj.2007.48.5.879","article-title":"Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm: evaluation of possible causes of aneurysm formation","volume":"48","author":"Sato","year":"2007","journal-title":"Yonsei Med J"},{"key":"2026080919370481400_EHU284C337","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C338","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0002-9149(81)90086-2","article-title":"Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration","volume":"48","author":"Rosing","year":"1981","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C339","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejheart.2008.03.006","article-title":"Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy","volume":"10","author":"Rogers","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026080919370481400_EHU284C340","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.amjcard.2012.04.030","article-title":"Cardiac transplantation in patients with hypertrophic cardiomyopathy","volume":"110","author":"Kato","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C341","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjcard.2007.09.085","article-title":"Heart transplantation in hypertrophic cardiomyopathy","volume":"101","author":"Biagini","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C342","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1399-3046.2008.01022.x","article-title":"Heart transplantation in infants with idiopathic hypertrophic cardiomyopathy","volume":"13","author":"Ragni","year":"2009","journal-title":"Pediatr Transplant"},{"key":"2026080919370481400_EHU284C343","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1053-2498(03)00225-0","article-title":"Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option","volume":"23","author":"Coutu","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"2026080919370481400_EHU284C344","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCHEARTFAILURE.109.922872","article-title":"Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy","volume":"3","author":"Maron","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C345","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1540-8191.2011.01331.x","article-title":"Use of a left ventricular assist device in hypertrophic cardiomyopathy","volume":"26","author":"Wynne","year":"2011","journal-title":"J Card Surg"},{"key":"2026080919370481400_EHU284C346","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCHEARTFAILURE.110.959288","article-title":"Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy","volume":"4","author":"Topilsky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C347","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/0002-8703(85)90357-6","article-title":"Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study","volume":"109","author":"Bourmayan","year":"1985","journal-title":"Am Heart J"},{"key":"2026080919370481400_EHU284C348","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/hrt.48.3.204","article-title":"Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs","volume":"48","author":"Alvares","year":"1982","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C349","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/hrt.56.6.544","article-title":"Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy","volume":"56","author":"Wilmshurst","year":"1986","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C350","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/01.CIR.79.5.1052","article-title":"Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy","volume":"79","author":"Udelson","year":"1989","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C351","first-page":"146","article-title":"Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function","volume":"16","author":"Pacileo","year":"2000","journal-title":"Can J Cardiol"},{"key":"2026080919370481400_EHU284C352","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C353","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2026080919370481400_EHU284C354","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0735-1097(10)80014-2","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study","volume":"15","author":"Robinson","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C355","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","article-title":"Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population","volume":"26","author":"Cecchi","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C356","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C357","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/euq013","article-title":"Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression","volume":"12","author":"Di Donna","year":"2010","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C358","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1540-8167.2008.01192.x","article-title":"Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"19","author":"Bunch","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919370481400_EHU284C359","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.amjcard.2006.12.087","article-title":"Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"99","author":"Gaita","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C360","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.hrthm.2005.11.013","article-title":"Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy","volume":"3","author":"Kilicaslan","year":"2006","journal-title":"Heart Rhythm"},{"key":"2026080919370481400_EHU284C361","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/europace\/euq434","article-title":"Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation","volume":"13","author":"McCready","year":"2011","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C362","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjcard.2003.10.025","article-title":"Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy","volume":"93","author":"Chen","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C363","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C364","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C365","doi-asserted-by":"crossref","first-page":"640723","DOI":"10.1155\/2013\/640723","article-title":"Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups","volume":"2013","author":"Gomez-Outes","year":"2013","journal-title":"Thrombosis"},{"key":"2026080919370481400_EHU284C366","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/hrt.2005.068577","article-title":"Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy","volume":"92","author":"Elliott","year":"2006","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C367","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(99)00056-X","article-title":"Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy","volume":"33","author":"Elliott","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C368","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM198805123181907","article-title":"Hypertrophic cardiomyopathy and sudden death","volume":"318","author":"Nicod","year":"1988","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C369","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0735-1097(86)80484-3","article-title":"Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy","volume":"7","author":"Stafford","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/hrt.43.3.245","article-title":"Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways","volume":"43","author":"Krikler","year":"1980","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C371","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/hrt.34.9.974","article-title":"Syncope in hypertrophic obstructive cardiomyopathy due to asystole","volume":"34","author":"Joseph","year":"1972","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C372","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0002-9149(98)00455-X","article-title":"Predictors of sudden cardiac death in hypertrophic cardiomyopathy","volume":"82","author":"Maki","year":"1998","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C373","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2004.12.067","article-title":"The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms","volume":"45","author":"Autore","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C374","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehi688","article-title":"Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy","volume":"27","author":"D'Andrea","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C375","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0002-9149(03)00266-2","article-title":"Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy","volume":"91","author":"Maron","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C376","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/hrt.79.4.331","article-title":"Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population","volume":"79","author":"Cecchi","year":"1998","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C377","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C378","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0735-1097(86)80092-4","article-title":"Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance","volume":"8","author":"Louie","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C379","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/europace\/eum093","article-title":"Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment","volume":"9","author":"Williams","year":"2007","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C380","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C381","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/01.CIR.82.6.1995","article-title":"Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy","volume":"82","author":"Frenneaux","year":"1990","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C382","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C383","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0735-1097(03)00253-5","article-title":"Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis","volume":"41","author":"Lee","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C384","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C385","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C386","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2012-303271","article-title":"A validation study of the 2003 American College of Cardiology\/European Society of Cardiology and 2011 American College of Cardiology Foundation\/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"99","author":"O'Mahony","year":"2013","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C387","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/europace\/eur362","article-title":"The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy","volume":"14","author":"O'Mahony","year":"2012","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C388","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1540-8159.2008.01174.x","article-title":"Circadian rhythm of appropriate implantable cardioverter defibrillator discharges in patients with hypertrophic cardiomyopathy","volume":"31","author":"Kiernan","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080919370481400_EHU284C389","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/hrt.53.4.412","article-title":"Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia","volume":"53","author":"McKenna","year":"1985","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C390","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/hrt.2006.099416","article-title":"Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy","volume":"93","author":"Melacini","year":"2007","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C391","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0735-1097(89)90302-1","article-title":"Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest","volume":"13","author":"Cecchi","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C392","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"2026080919370481400_EHU284C393","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1540-8167.2009.01716.x","article-title":"Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up","volume":"21","author":"Syska","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919370481400_EHU284C394","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026080919370481400_EHU284C395","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/eurheartj\/ehi325","article-title":"Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology","volume":"26","author":"Pelliccia","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C396","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/hrt.2008.150656","article-title":"Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy","volume":"95","author":"Lin","year":"2009","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C397","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.hrthm.2005.05.008","article-title":"Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy","volume":"2","author":"Almquist","year":"2005","journal-title":"Heart Rhythm"},{"key":"2026080919370481400_EHU284C398","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1540-8167.2010.01943.x","article-title":"Defibrillation thresholds in hypertrophic cardiomyopathy","volume":"22","author":"Quin","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919370481400_EHU284C399","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1540-8159.2010.02843.x","article-title":"Defibrillation threshold testing in patients with hypertrophic cardiomyopathy","volume":"33","author":"Roberts","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080919370481400_EHU284C400","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1253\/circj.CJ-08-0744","article-title":"QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy","volume":"73","author":"Nagai","year":"2009","journal-title":"Circ J"},{"key":"2026080919370481400_EHU284C401","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1540-8167.2007.00780.x","article-title":"Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy","volume":"18","author":"Cha","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080919370481400_EHU284C402","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C403","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/europace\/euq316","article-title":"Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management","volume":"12","author":"Braunschweig","year":"2010","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C404","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C405","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/europace\/eut016","article-title":"United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn","volume":"15","author":"Jarman","year":"2013","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C406","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C407","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C408","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C409","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C410","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jacc.2009.03.051","article-title":"Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children","volume":"54","author":"Decker","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C411","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1017\/S1047951105001824","article-title":"Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly","volume":"15","author":"Ostman-Smith","year":"2005","journal-title":"Cardiol Young"},{"key":"2026080919370481400_EHU284C412","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jacc.2011.04.039","article-title":"Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry","volume":"58","author":"Dewland","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C413","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0003-4975(97)01434-3","article-title":"Implantable cardioverter-defibrillators in children: a single-institutional experience","volume":"65","author":"Wilson","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"2026080919370481400_EHU284C414","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/hrt.2006.094730","article-title":"Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy","volume":"93","author":"Kaski","year":"2007","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C415","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2010.08.026","article-title":"Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy","volume":"153","author":"Efthimiadis","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026080919370481400_EHU284C416","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.hrthm.2010.10.010","article-title":"Biventricular pacing in hypertrophic obstructive cardiomyopathy: a pilot study","volume":"8","author":"Berruezo","year":"2011","journal-title":"Heart Rhythm"},{"key":"2026080919370481400_EHU284C417","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.CIR.59.5.866","article-title":"Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy","volume":"59","author":"Savage","year":"1979","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C418","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.90.6.2743","article-title":"Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia","volume":"90","author":"Spirito","year":"1994","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C419","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.ijcard.2010.02.071","article-title":"Arrhythmogenic left ventricular apical aneurysm in hypertrophic cardiomyopathy","volume":"151","author":"Morner","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026080919370481400_EHU284C420","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/europace\/eus241","article-title":"Epicardial ablation of monomorphic ventricular tachycardia storm in hypertrophic cardiomyopathy","volume":"15","author":"Bordignon","year":"2013","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C421","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/europace\/eus198","article-title":"Epicardial ablation of monomorphic ventricular tachycardia in a case of hypertrophic cardiomyopathy with apical aneurysm","volume":"15","author":"Wong","year":"2013","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C422","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.110.957290","article-title":"Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy","volume":"4","author":"Dukkipati","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080919370481400_EHU284C423","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jacc.2009.01.079","article-title":"Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study","volume":"54","author":"Sorajja","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C424","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2012.03.076","article-title":"Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"60","author":"Todiere","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C425","first-page":"11","article-title":"Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy","volume":"29","author":"Olivotto","year":"1999","journal-title":"G Ital Cardiol"},{"key":"2026080919370481400_EHU284C426","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.amjcard.2012.01.363","article-title":"Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"109","author":"Sorajja","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C427","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C428","article-title":"Saving Mothers Lives: Reviewing Maternal Deaths to make motherhood safer \u2013 2003\u20132005. The seventh report on confidential enquiries into maternal detahs in the United Kingdom","author":"Confidential Enquiry into Maternal and Child Health (CEMACH)","year":"2008"},{"key":"2026080919370481400_EHU284C429","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11886-009-0043-7","article-title":"Choosing the best contraceptive method for the adult with congenital heart disease","volume":"11","author":"Silversides","year":"2009","journal-title":"Curr Cardiol Rep"},{"key":"2026080919370481400_EHU284C430","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/hc3001.093437","article-title":"Prospective multicenter study of pregnancy outcomes in women with heart disease","volume":"104","author":"Siu","year":"2001","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C431","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0735-1097(02)02495-6","article-title":"Risk associated with pregnancy in hypertrophic cardiomyopathy","volume":"40","author":"Autore","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C432","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1590\/S0066-782X2007000400019","article-title":"Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy","volume":"88","author":"Avila","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"2026080919370481400_EHU284C433","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/heart.89.7.752","article-title":"Pregnancy related complications in women with hypertrophic cardiomyopathy","volume":"89","author":"Thaman","year":"2003","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C434","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/eurjhf\/hfr040","article-title":"Systematic review of pregnancy in women with inherited cardiomyopathies","volume":"13","author":"Krul","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080919370481400_EHU284C435","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/europace\/eus172","article-title":"Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience","volume":"14","author":"Schuler","year":"2012","journal-title":"Europace"},{"key":"2026080919370481400_EHU284C436","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/eurheartj\/ehq200","article-title":"Predictors of pregnancy complications in women with congenital heart disease","volume":"31","author":"Drenthen","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C437","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.110.953380","article-title":"Heart rate response during exercise and pregnancy outcome in women with congenital heart disease","volume":"123","author":"Lui","year":"2011","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C438","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0002-9378(90)90416-5","article-title":"The effect of disopyramide on uterine contractions during pregnancy","volume":"162","author":"Tadmor","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"2026080919370481400_EHU284C439","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0002-9378(95)91498-6","article-title":"Pregnancy outcome after gestational exposure to amiodarone in Canada","volume":"172","author":"Magee","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"2026080919370481400_EHU284C440","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00002018-199920010-00008","article-title":"Treatment of cardiac arrhythmias during pregnancy: safety considerations","volume":"20","author":"Joglar","year":"1999","journal-title":"Drug Saf"},{"key":"2026080919370481400_EHU284C441","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12471-011-0077-5","article-title":"Electrical cardioversion during pregnancy: safe or not?","volume":"19","author":"Tromp","year":"2011","journal-title":"Neth Heart J"},{"key":"2026080919370481400_EHU284C442","first-page":"485","article-title":"Hyperthrophic obstructive cardiomyopathy and pregnancy: University College London Hospital experience","volume":"73","author":"Walker","year":"2007","journal-title":"Minerva Anestesiol"},{"key":"2026080919370481400_EHU284C443","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pcad.2012.01.003","article-title":"Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy","volume":"54","author":"Pelliccia","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080919370481400_EHU284C444","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/CIRCULATIONAHA.106.613562","article-title":"The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C445","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0002-9149(94)90439-1","article-title":"Morphology of the \u201cathlete's heart\u201d assessed by echocardiography in 947 elite athletes representing 27 sports","volume":"74","author":"Spirito","year":"1994","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C446","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199101313240504","article-title":"The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes","volume":"324","author":"Pelliccia","year":"1991","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C447","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jama.1996.03540030045030","article-title":"Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes","volume":"276","author":"Pelliccia","year":"1996","journal-title":"JAMA"},{"key":"2026080919370481400_EHU284C448","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.amjcard.2010.10.049","article-title":"Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities","volume":"107","author":"Biffi","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C449","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.amjcard.2008.02.081","article-title":"Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes","volume":"101","author":"Biffi","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C450","doi-asserted-by":"crossref","first-page":"i51","DOI":"10.1136\/bjsports-2011-090838","article-title":"Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum","volume":"46 Suppl 1","author":"Wilson","year":"2012","journal-title":"Br J Sports Med"},{"key":"2026080919370481400_EHU284C451","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/CS20060293","article-title":"Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis","volume":"112","author":"Konno","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"2026080919370481400_EHU284C452","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/eurheartj\/ehp473","article-title":"Recommendations for interpretation of 12-lead electrocardiogram in the athlete","volume":"31","author":"Corrado","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C453","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jcmg.2008.09.002","article-title":"Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies","volume":"1","author":"Afonso","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919370481400_EHU284C454","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0735-1097(87)80264-4","article-title":"Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy","volume":"10","author":"Maron","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C455","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/hc0802.104534","article-title":"Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning","volume":"105","author":"Pelliccia","year":"2002","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C456","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/hrt.69.2.125","article-title":"Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes","volume":"69","author":"Maron","year":"1993","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C457","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/eurheartj\/ehr140","article-title":"The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African\/Afro-Caribbean origin","volume":"32","author":"Papadakis","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C458","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/bjsports-2012-091874","article-title":"Cardiac adaptation to exercise in adolescent athletes of African ethnicity: an emergent elite athletic population","volume":"47","author":"Sheikh","year":"2013","journal-title":"Br J Sports Med"},{"key":"2026080919370481400_EHU284C459","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/echo.12014","article-title":"Efficacy of various \u201cclassic\u201d echocardiographic and laboratory indices in distinguishing the \u201cgray zone\u201d between athlete's heart and hypertrophic cardiomyopathy: a pilot study","volume":"30","author":"Pagourelias","year":"2013","journal-title":"Echocardiography"},{"key":"2026080919370481400_EHU284C460","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCGENETICS.112.963363","article-title":"Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy","volume":"6","author":"Gruner","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"2026080919370481400_EHU284C461","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","article-title":"Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies","volume":"275","author":"Schmieder","year":"1996","journal-title":"JAMA"},{"key":"2026080919370481400_EHU284C462","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"key":"2026080919370481400_EHU284C463","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","article-title":"Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events","volume":"292","author":"Okin","year":"2004","journal-title":"JAMA"},{"key":"2026080919370481400_EHU284C464","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/hc0702.104162","article-title":"Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial","volume":"105","author":"Skudicky","year":"2002","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C465","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.108.826214","article-title":"Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy","volume":"119","author":"Solomon","year":"2009","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C466","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"key":"2026080919370481400_EHU284C467","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bmj.39276.636354.AE","article-title":"Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review","volume":"335","author":"Pewsner","year":"2007","journal-title":"BMJ"},{"key":"2026080919370481400_EHU284C468","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mhj.2002.124863","article-title":"Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension","volume":"144","author":"Olsen","year":"2002","journal-title":"Am Heart J"},{"key":"2026080919370481400_EHU284C469","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1067\/mhj.2002.121926","article-title":"Associations between angiotensinogen gene variants and left ventricular mass and function in the HyperGEN study","volume":"143","author":"Tang","year":"2002","journal-title":"Am Heart J"},{"key":"2026080919370481400_EHU284C470","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpeds.2007.05.053","article-title":"Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension","volume":"152","author":"Brady","year":"2008","journal-title":"J Pediatr"},{"key":"2026080919370481400_EHU284C471","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1081\/JCMR-200060631","article-title":"Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance","volume":"7","author":"Petersen","year":"2005","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919370481400_EHU284C472","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00330-011-2065-y","article-title":"Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation","volume":"21","author":"Sipola","year":"2011","journal-title":"Eur Radiol"},{"key":"2026080919370481400_EHU284C473","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjcard.2010.05.036","article-title":"Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy","volume":"106","author":"Puntmann","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C474","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000154822.37141.f6","article-title":"Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value","volume":"45","author":"Verdecchia","year":"2005","journal-title":"Hypertension"},{"key":"2026080919370481400_EHU284C475","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ajh.2012.31","article-title":"Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy","volume":"25","author":"Gerdts","year":"2012","journal-title":"Am J Hypertens"},{"key":"2026080919370481400_EHU284C476","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08037051.2010.514713","article-title":"Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice","volume":"20","author":"Cuspidi","year":"2011","journal-title":"Blood Press"},{"key":"2026080919370481400_EHU284C477","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1464-5491.2011.03383.x","article-title":"Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial","volume":"29","author":"Fogari","year":"2012","journal-title":"Diabet Med"},{"key":"2026080919370481400_EHU284C478","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/HYPERTENSIONAHA.111.00904","article-title":"Relationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease","volume":"62","author":"Peterson","year":"2013","journal-title":"Hypertension"},{"key":"2026080919370481400_EHU284C479","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0002-9149(01)01585-5","article-title":"Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes","volume":"88","author":"Vinereanu","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C480","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1161\/01.CIR.0000150334.69355.00","article-title":"Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography","volume":"110","author":"Kato","year":"2004","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C481","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000006847","article-title":"Outflow acceleration assessed by continuous-wave doppler echocardiography in left ventricular hypertrophy: an analysis of 103 consecutive cases","volume":"90","author":"Faber","year":"1998","journal-title":"Cardiology"},{"key":"2026080919370481400_EHU284C482","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ejechocard\/jen070","article-title":"Dynamic left ventricular outflow tract obstruction evoked by exercise echocardiography: prevalence and predictive factors in a prospective study","volume":"9","author":"Zywica","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"2026080919370481400_EHU284C483","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/01.CIR.58.3.402","article-title":"Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy","volume":"58","author":"Savage","year":"1978","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C484","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.amjcard.2005.03.058","article-title":"Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy","volume":"96","author":"Montgomery","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C485","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM198709243171302","article-title":"Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy","volume":"317","author":"McLenachan","year":"1987","journal-title":"N Engl J Med"},{"key":"2026080919370481400_EHU284C486","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0002-9149(90)91381-F","article-title":"Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy","volume":"65","author":"Siegel","year":"1990","journal-title":"Am J Cardiol"},{"key":"2026080919370481400_EHU284C487","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00004872-200102000-00002","article-title":"Arterial hypertension and cardiac arrhythmias","volume":"19","author":"Hennersdorf","year":"2001","journal-title":"J Hypertens"},{"key":"2026080919370481400_EHU284C488","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4065\/81.4.459","article-title":"Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations","volume":"81","author":"Binder","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"2026080919370481400_EHU284C489","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1253\/circj.68.968","article-title":"Beneficial effect of cibenzoline on left ventricular pressure gradient with sigmoid septum","volume":"68","author":"Konishi","year":"2004","journal-title":"Circ J"},{"key":"2026080919370481400_EHU284C490","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.hlc.2011.05.002","article-title":"Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy","volume":"20","author":"Ranasinghe","year":"2011","journal-title":"Heart Lung Circ"},{"key":"2026080919370481400_EHU284C491","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/08037051.2010.481816","article-title":"Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy)","volume":"19","author":"Tuseth","year":"2010","journal-title":"Blood Press"},{"key":"2026080919370481400_EHU284C492","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1532-429X-14-50","article-title":"Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance","volume":"14","author":"Dweck","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080919370481400_EHU284C493","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C494","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jtcvs.2011.10.096","article-title":"Asymmetric septal hypertrophy in patients with severe aortic stenosis: the usefulness of associated septal myectomy","volume":"145","author":"Di Tommaso","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080919370481400_EHU284C495","first-page":"576","article-title":"Aortic regurgitation in hypertrophic cardiomyopathy","volume":"41","author":"Kar","year":"1993","journal-title":"J Assoc Physicians India"},{"key":"2026080919370481400_EHU284C496","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/hrt.62.3.171","article-title":"Aortic regurgitation associated with hypertrophic cardiomyopathy: a colour Doppler echocardiographic study","volume":"62","author":"Shiota","year":"1989","journal-title":"Br Heart J"},{"key":"2026080919370481400_EHU284C497","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0735-1097(92)90493-7","article-title":"Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy","volume":"19","author":"Roberts","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C498","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0003-4975(91)90316-I","article-title":"Aortic regurgitation after left ventricular myotomy and myectomy","volume":"51","author":"Brown","year":"1991","journal-title":"Ann Thorac Surg"},{"key":"2026080919370481400_EHU284C499","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0735-1097(89)90550-0","article-title":"Aortic regurgitation: a common complication after surgery for hypertrophic obstructive cardiomyopathy","volume":"13","author":"Sasson","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"2026080919370481400_EHU284C500","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ejechocard\/jeq031","article-title":"European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"2026080919370481400_EHU284C501","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.CIR.99.16.2132","article-title":"Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis","volume":"99","author":"Spirito","year":"1999","journal-title":"Circulation"},{"key":"2026080919370481400_EHU284C502","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/oxfordjournals.eurheartj.a059632","article-title":"Hypertrophic obstructive cardiomyopathy and infective endocarditis: a report of seven cases and a review of the literature","volume":"11","author":"Alessandri","year":"1990","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C503","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","article-title":"Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919370481400_EHU284C504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejcnurse.2010.01.001","article-title":"Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators","volume":"9","author":"Vijgen","year":"2010","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2026080919370481400_EHU284C505","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/hrt.2010.203091","article-title":"Fitness to fly for passengers with cardiovascular disease","volume":"96 Suppl 2","author":"Smith","year":"2010","journal-title":"Heart"},{"key":"2026080919370481400_EHU284C506","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","article-title":"Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy","volume":"54","author":"Bos","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/35\/39\/2733\/70579346\/eurheartj_35_39_2733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/35\/39\/2733\/70579346\/eurheartj_35_39_2733.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:39:16Z","timestamp":1786318756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/35\/39\/2733\/853385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,29]]},"references-count":506,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2014,8,29]]},"published-print":{"date-parts":[[2014,10,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehu284","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,10,14]]},"published":{"date-parts":[[2014,8,29]]}}}